Oct 19, 2016 at 13:20 | Source: PTI
Sun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.
Oct 19, 2016 at 12:26 | Source: Moneycontrol.com
International Centre for Genetic Engineering and Biotechnology and Sun Pharma today announced their new collaboration for development of a dengue vaccine.
Oct 06, 2016 at 17:30 | Source: PTI
"As soon as the government approves the use of the Sanofi Pasteur dengue vaccine, it will take minimally 6-8 months to complete the remaining regulatory requirements and make the vaccine available to the Indian population," Baylet said.
Sep 26, 2016 at 11:32 | Source: CNBC-TV18
In an interview with CNBC-TV18, Devi Shetty, Chairman of Narayana Hrudayalaya said that dengue is a global problem but India is not doing enough to prevent it.
Sep 20, 2016 at 11:56 | Source: Moneycontrol.com
The agreement includes early stage development to the final commercialisation of the vaccine.
Sep 07, 2016 at 11:32 | Source: CNBC-TV18
The company is focusing on vaccinations for dengue and pneumonia solutions and sending them to Asian & African countries, said Adar Poonawalla,CEO & Executive Director, Serum Institute of India.
Aug 24, 2016 at 14:33 | Source: CNBC-TV18
In earnings' conference call, Jhunjhunwala who currently holds 1.12 percent stake in the company threw a volley of questions to the management. The big bull raised questions on Aurobindo Pharma's finance cost, capex, rationale behind investment in vaccines, product launch, potential revenue growth and its fund raising plans.
Aug 23, 2016 at 19:40 | Source: PTI
Chennai-based GreenSignal Bio Pharma is likely to come out with an Initial Public Offer (IPO) in October to raise around Rs 100 crore.
Aug 15, 2016 at 17:30 | Source: PTI
Vaccines segment is another addition to the company's differentiated portfolio where there are unmet needs and limited competition, Aurobindo Pharma said in its annual report.
Jul 29, 2016 at 15:10 | Source: CNBC-TV18
Twenty three percent revenue run rate is sustainable for the full year, said Rajiv Gandhi, CEO & MD of Hester Biosciences.